CRP and pancreatic adenocarcinoma: The association between high CRP to PDAC remains innovative: in fact, this inflammatory marker has been associated with poor survival after resection and with low resectability rate but never with histologic origin (primary pancreatic adenocarcinoma, PDAC) [37, 38].